Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Pucci

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 28, 2015
Resolution of septic shock in a patient with myelomeningocele (spina bifida) complicated with deforming Elephantiasis Nostras VerrucosaS Barberi, A Manzione, J Scrivano, et al.
European Journal of Neurology|March 19, 2010
Ethical issues in end of life treatments for patients with dementiaM Congedo, R I Causarano, F Alberti, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 11, 2007
Ethical questions in the treatment of subjects with dementia. Part I. Respecting autonomy: awareness, competence and behavioural disordersC A Defanti, A Tiezzi, M Gasparini, et al.
European Journal of Neurology|January 20, 2016
Risk of early relapse following the switch from injectables to oral agents for multiple sclerosisT Spelman, L Mekhael, T Burke, et al.
Journal of Neurology|January 8, 2025
Implementing proximity care for people with multiple sclerosis in Italy: the bottom-up approach of the StayHome projectM Filippi, P Gallo, C Gasperini, et al.
European Journal of Neurology|March 27, 2015
BREMSO: a simple score to predict early the natural course of multiple sclerosisR Bergamaschi, C Montomoli, G Mallucci, et al.
European Journal of Neurology|October 10, 2018
Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort studyJ Lorscheider, J Kuhle, G Izquierdo, et al.
International Journal of Immunopathology and Pharmacology|July 10, 2014
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in ItalyR Totaro, A Lugaresi, P Bellantonio, et al.
European Journal of Neurology|October 10, 2018
Management of psychogenic non-epileptic seizures: a multidisciplinary approachS Gasparini, E Beghi, E Ferlazzo, et al.
Journal of Medical Economics|December 12, 2023
Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United KingdomT Spelman, W L Herring, C Acosta, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 28, 2015
Resolution of septic shock in a patient with myelomeningocele (spina bifida) complicated with deforming Elephantiasis Nostras VerrucosaS Barberi, A Manzione, J Scrivano, et al.
European Journal of Neurology|March 19, 2010
Ethical issues in end of life treatments for patients with dementiaM Congedo, R I Causarano, F Alberti, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 11, 2007
Ethical questions in the treatment of subjects with dementia. Part I. Respecting autonomy: awareness, competence and behavioural disordersC A Defanti, A Tiezzi, M Gasparini, et al.
European Journal of Neurology|January 20, 2016
Risk of early relapse following the switch from injectables to oral agents for multiple sclerosisT Spelman, L Mekhael, T Burke, et al.
Journal of Neurology|January 8, 2025
Implementing proximity care for people with multiple sclerosis in Italy: the bottom-up approach of the StayHome projectM Filippi, P Gallo, C Gasperini, et al.
European Journal of Neurology|March 27, 2015
BREMSO: a simple score to predict early the natural course of multiple sclerosisR Bergamaschi, C Montomoli, G Mallucci, et al.
European Journal of Neurology|October 10, 2018
Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort studyJ Lorscheider, J Kuhle, G Izquierdo, et al.
International Journal of Immunopathology and Pharmacology|July 10, 2014
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in ItalyR Totaro, A Lugaresi, P Bellantonio, et al.
European Journal of Neurology|October 10, 2018
Management of psychogenic non-epileptic seizures: a multidisciplinary approachS Gasparini, E Beghi, E Ferlazzo, et al.
Journal of Medical Economics|December 12, 2023
Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United KingdomT Spelman, W L Herring, C Acosta, et al.
Pageof 9